During the past decade, ABQ Eye Care conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ABQ Eye Care" are "Visual Acuity" (3 trials) and "Visual Performance" (1 trials). Many other conditions were trialed in "ABQ Eye Care" in a lesser frequency.

Most popular intervention types in "ABQ Eye Care" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "ACUVUE Oasys 1-Day" (1 trials), "Investigational Contact Lens" (1 trials), "Marketed Contact Lens" (1 trials), "Multifocal Contact Lens 1" (1 trials) and "Multifocal Contact Lens 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "ABQ Eye Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ABQ Eye Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in ABQ Eye Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ABQ Eye Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".